Table 1.
Participant Number | Gender | Diagnosis | Age at Entry | Number of Tests Completed | Medication Pre-Remission | Medication Pre-Relapse |
---|---|---|---|---|---|---|
1 | Male | SZ | 21.8 | 24 | risperidone 2.0 mg/day | risperidone 2.0 mg/day |
2 | Female | SZ | 25.4 | 49 | risperidone 4.5 mg/day | risperidone 4.5 mg/day |
3 | Male | SZ | 22.8 | 58 | risperidone 6.0 mg/day | risperidone 7.5 mg/day |
4 | Male | SZ | 38.0 | 72 | olanzapine 10.0 mg/day | olanzapine 10.0 mg/day |
5 | Male | SZ | 41.0 | 30 | fluphenazine 10.0 mg/day | fluphenazine 9.0 mg/day |
6 | Female | SZAFF | 41.3 | 43 | olanzapine 10.0 mg/day fluphenazine 6.25 mg/day | olanzapine 50.0 mg/day fluphenazine 10.0 mg/day |